The APRLO is WFPHA regional office for Asia Pacific. It coordinates with countries throughout the region to improve and protect publics' health.

2024World Influenza Conference Abstract Submission Now Open!


2024 World Influenza Conference

July6th – 7th in Boao, Hainan, China

Call for Abstracts

About WIC:

In order to strengthen exchanges, communication and cooperation among experts and scholars in the field of global influenza and respiratory infectious disease prevention and treatment, and to enhance the level of comprehensive prevention, treatment and response, Chinese Preventive Medicine Association(CPMA), Asia-Pacific Alliance for the Control of Influenza (APACI), Chinese Centre for Disease Control and Prevention (China CDC) and Chinese Academy of Medical Sciences (CAMS) jointly initiated the World Influenza Conference, which has been held every two years and has been convened three times consecutively since 2018, which has had a broad and profound impact.

The coexistence of multiple respiratory infectious diseases such as influenza and COVID-19 in the world poses a major challenge to susceptible populations and healthcare delivery systems, and poses a serious threat to global public health. WHO recommends that countries set a target of 75% influenza vaccination coverage for target populations. However,influenza vaccine coverage among susceptible groups remains low in many countries and falls far short of the target.

Call for abstracts:

In order to promote academic exchanges in the field and enhance the consensus on the prevention and treatment of respiratory diseases, CPMA, together with APACI, China CDC and CAMS plan to hold the 2024 World Influenza Conference from July 6th to 7th, 2024, in Boao, Hainan, China, under the theme of "From Influenza to Respiratory Infectious Diseases".

2024WIC welcomes the submission of abstracts for original contributions to the relevant field. We encourage work that introduces new ideas, concepts and research and deepens understanding in the field. Please read the following guidelines carefully before submitting your abstract:


Submission: Abstracts can be submitted only online through the “Abstract Submission” column on 2024 WIC official website (https://2024wic.xxnet.top/en/). Submissions by fax, post or email will not be considered.

Language: As the official 2024WIC language is English, all abstracts must be in English. If English is not your native language, please arrange for a native English speaker to review your abstract before submission.

Important dates:

20 Feburary 2024 : Online abstract submission opens.

30 April 2024, 23:59 Chinese Standard Time: Abstract submission closes. Abstracts, as well as amendments to submitted abstracts, will not be accepted after this date.

Selection and awards: Abstracts submitted to 2024WIC will be reviewed by the Conference Academic Committee. The highest-scoring abstracts will be selected for oral presentation (10 minutes) in a parallel session, or as e-posters to be displayed on the conference website. Abstracts accepted will be compiled in the 2024 World Influenza Conference Abstracts. Outstanding abstracts will be recommended for further publication in relevant international journals as appropriate.

Major contents:

1.Influenza and COVID-19 vaccines research and development: vaccination strategies, vaccine equity and distribution, vaccine research and development, new technologies in vaccine R&D and real-world studies, etc.

2. Clinical presentations and treatment for influenza and other respiratory infections: epidemiology and clinical manifestations of respiratory infections, clinical evidence for drug therapy, standardized treatment, and research on anti-infective drugs, etc.

3. Revisiting the global readiness of pandemic preparedness plans: how to better respond to the next pandemic, capacity building for emergency preparedness and response, pandemic preparedness plans, strategy and status of emergency response plans, etc.

4. Influenza and COVID-19 knowledge awareness and pandemic risk communication: public health communication and community engagement, health communication and popularisation, vaccine hesitancy, challenges in influenza vaccine policy formulation, etc.

5. Multi-pathogen surveillance and diagnosis on influenza and other respiratory diseases:effectiveness of rapid diagnostic techniques, early warning on emerging pathogens, integrated surveillance on respiratory diseases, combined detection of respiratory multi-pathogens, etc.


1.Format: Abstract submission requires clear arguments, concise writing and reliable data.The abstract should be in structured format, written in a four-paragraph format including Objective, Methods, Results, and Conclusions, and an indicative abstract could be used for Research Review papers. 3-8 keywords should be given.

2. Word limits: The abstract is limited to 500-800 words.

3.Font: Use Times New Roman font when formatting the text.

4. Abstract submissions should include the First author's name, affiliation, position and title, contact number and email address.

5. A detailed example of the format is attached (Annex).


1.Papers corresponding to abstracts submitted to 2024WIC should not have been published in other academic conferences or journals.

2. Abstracts must not include libellous or defamatory content. Material presented in abstracts must not violate any copyright laws.

3. The submission of an abstract constitutes the author(s)consent for publication.Authors retain the copyright of their abstract, with first publication rights granted to 2024WIC.


2024 World Influenza Conference

Formatting Requirements for Abstract Submissions

Abstracts must include: Title, Author's Name and Information (organization, province and city name and postal code, E-mail address), Abstract, Keywords, Reporter's profile (including address, Email and contact phone number), please do not missing items. All submissions must be in English, and the font formatting requirements are as following:

1.Thesis title: Times New Roman font, size 14, bold; centred; the first letter of the first word is capitalised and the rest of the words are lower case.

2.Author's name: Times New Roman font, size 10.5; centred; Chinese name in Chinese Pinyin, first name in the front, last name in the back, and the first letter capitalised. For two or more authors, names are separated by ",".

3.Author information: Times New Roman font, size 10.5; centred; italicised. The name of the organisation, province or city needs to be listed. Corresponding authors are underlined. After the author's information, the contact email address of the paper should be indicated in a new line. The organization should be detailed to the second level (e.g. university: faculty; research institute: department, office).

4.Abstract: Times New Roman font, size 10.5; 500-800 words. Written in structured abstract format, which is four-paragraph format of Objective, Methods, Results and Conclusions, with "Objective, Methods, Results and Conclusions" in bold; abstracts of the research review papers may use indicative abstracts.

5.Keywords: Times New Roman font, size 10.5; 3 to 5 keywords, spaced by semicolons.

6.Author's profile: Times New Roman font, size 10.5, including Photo, education degree, position and title, main research direction, contact information (E-mail address and telephone number).

7.Formatting specifications

7.1 Page setup: A4; margins are 2.5 cm left and right, 3 cm top and bottom.

7.2 Line spacing: single-spaced; one blank line after the Title, after Author information, and after Keywords.


Clinical research progress and application of respiratory mucosal immunization vaccines

San Zhang1, Si Li2, Wu Wang1

1.Department, School, Beijing, China; 2.Division, Institute, Beijing, China…

Contact email address: Author Name (111111@abc.com); Corresponding author name (If available,123456@abc.com)

Objective: To…….

Methods: Through …….

Results:It has been found…….

Conclusions:It is suggested…...

Keywords: word 1; word 2; word 3; word 4…

Introduction of the reporter:Photo, Education degree, Position/Title, Organization, Major research interests, Contact information (Tel and Email)

【Annex】2024WIC abstract submission format requirements and example